Condition
Post Stroke Epilepsy
Total Trials
5
Recruiting
1
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 15/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
2Total
P 2 (1)
P 4 (1)
Trial Status
Unknown2
Enrolling By Invitation1
Recruiting1
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06108102Enrolling By InvitationPrimary
International Post-Stroke Epilepsy Research Repository
NCT05864547RecruitingPrimary
Predisposing Factors for Post-stroke Epilepsy
NCT06597084Phase 2CompletedPrimary
Anti-epileptogenic Effects of Eslicarbazepine Acetate
NCT05987397Phase 4UnknownPrimary
Exploring the Preventive Effect of Mitochondrial Protective Agent Idebenone on Post-stroke Epilepsy
NCT03848273Unknown
Post Stroke Epileptic Seizures Risk Forecast
Showing all 5 trials